Balance Medical(SH:688198) Zheng Quan Zhi Xing·2025-07-24 16:20Core Viewpoint - The announcement details the results of the fifth vesting period of the 2020 Restricted Stock Incentive Plan and the third vesting period of the reserved grant, with shares set to be listed on July 29, 2025 [2][18]. Summary by Sections Stock Listing and Vesting Details - The total number of shares to be listed is 352,985, which are part of the equity incentive shares [2]. - The shares were registered on July 23, 2025, following the completion of the vesting conditions [2][11]. Decision-Making Process - The decision-making process for the vesting of restricted stocks involved multiple board meetings and approvals, including the first board meeting on June 30, 2020, where the incentive plan was approved [2][4]. - Independent directors provided their consent on the proposals related to the incentive plan [2][4]. Vesting Conditions and Results - A total of 107 individuals are eligible for the vesting, with 65 from the initial grant and 44 from the reserved grant [16]. - The total number of shares vested includes 26,777.2 shares from the initial grant and 24,688.7 shares from the reserved grant [12][14]. Financial Impact - The company reported a net profit of approximately RMB 32.5 million for Q1 2025, with the basic earnings per share expected to be diluted due to the increase in total shares to 137,748,133 [17]. - The new shares will affect the earnings per share calculation based on the unchanged net profit [17]. Stock Source and Registration - The shares for this vesting are sourced from the company's directed issuance of A-shares to the incentive recipients [15]. - The verification of the investment contributions from the incentive recipients was completed, confirming a total investment of RMB 5,333,603.35 [17].